# Fermi Inc.: financial statements, quarterly

FRMI · Nasdaq · CIK 2071778 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frmi.md) · [Financials](/companies/frmi/financials.md) · [Filings](/companies/frmi/filings.md) · [Insiders](/companies/frmi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frmi/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(0.1)](/filings/0002071778-26-000032.md) | [(5.6)](/filings/0002071778-26-000051.md) | [(37.8)](/filings/0001213900-25-109371.md) | [(134) d](/filings/0002071778-26-000010.md) | [(166)](/filings/0002071778-26-000032.md) | [(26.8)](/filings/0002071778-26-000051.md) |
| Interest expense | $m | [0.0](/filings/0002071778-26-000032.md) | [0.7](/filings/0002071778-26-000051.md) | [(0.0)](/filings/0001213900-25-109371.md) | [(4.4) d](/filings/0002071778-26-000010.md) | [(2.3)](/filings/0002071778-26-000032.md) | [(1.0)](/filings/0002071778-26-000051.md) |
| Net income | $m | [(0.1)](/filings/0002071778-26-000051.md) | [(6.3)](/filings/0002071778-26-000051.md) | [(347)](/filings/0001213900-25-109371.md) | [(133) d](/filings/0002071778-26-000010.md) | [(189)](/filings/0002071778-26-000051.md) | [(25.8)](/filings/0002071778-26-000051.md) |
| Diluted EPS | $ per share | [0.00](/filings/0002071778-26-000032.md) | [(0.02)](/filings/0002071778-26-000051.md) | [(0.84)](/filings/0001213900-25-109371.md) | not reported | [(0.30)](/filings/0002071778-26-000032.md) | [(0.04)](/filings/0002071778-26-000051.md) |
| Basic EPS | $ per share | [0.00](/filings/0002071778-26-000032.md) | [(0.02)](/filings/0002071778-26-000051.md) | [(0.84)](/filings/0001213900-25-109371.md) | not reported | [(0.30)](/filings/0002071778-26-000032.md) | [(0.04)](/filings/0002071778-26-000051.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-01-10) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.2](/filings/0002071778-26-000032.md) | [40.3](/filings/0002071778-26-000051.md) | [83.7](/filings/0001213900-25-109371.md) | [409](/filings/0002071778-26-000051.md) | [208](/filings/0002071778-26-000032.md) | [62.5](/filings/0002071778-26-000051.md) |
| Total assets | $m | not reported | not reported | not reported | [503](/filings/0001213900-25-109371.md) | [1,413](/filings/0002071778-26-000051.md) | [1,777](/filings/0002071778-26-000032.md) | [1,763](/filings/0002071778-26-000051.md) |
| Total liabilities | $m | not reported | not reported | not reported | [200](/filings/0001213900-25-109371.md) | [317](/filings/0002071778-26-000051.md) | [705](/filings/0002071778-26-000032.md) | [731](/filings/0002071778-26-000051.md) |
| Long-term debt | $m | not reported | not reported | not reported | [154](/filings/0001213900-25-109371.md) | [110](/filings/0002071778-26-000051.md) | [421](/filings/0002071778-26-000032.md) | [520](/filings/0002071778-26-000051.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [103](/filings/0001213900-25-109371.md) | [110](/filings/0002071778-26-000051.md) | [421](/filings/0002071778-26-000032.md) | [520](/filings/0002071778-26-000051.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [154](/filings/0001213900-25-109371.md) | [149](/filings/0002071778-26-000010.md) | not reported | not reported |
| Shareholders' equity | $m | [0.0](/filings/0002071778-26-000051.md) | [0.4](/filings/0002071778-26-000051.md) | [(1.8)](/filings/0002071778-26-000051.md) | [302](/filings/0001213900-25-109371.md) | [1,096](/filings/0002071778-26-000051.md) | [1,072](/filings/0002071778-26-000051.md) | [1,032](/filings/0002071778-26-000051.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.0)](/filings/0002071778-26-000032.md) | [(2.6) d](/filings/0002071778-26-000051.md) | [(5.7) d](/filings/0001213900-25-109371.md) | [(25.9) d](/filings/0002071778-26-000010.md) | [(7.3)](/filings/0002071778-26-000032.md) | [(48.7) d](/filings/0002071778-26-000051.md) |
| Capital expenditure | $m | [0.0](/filings/0002071778-26-000032.md) | [40.3 d](/filings/0002071778-26-000051.md) | [0.2](/filings/0001213900-25-109371.md) | [480 d](/filings/0002071778-26-000010.md) | [441](/filings/0002071778-26-000032.md) | [185 d](/filings/0002071778-26-000051.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [73.7](/filings/0002071778-26-000032.md) | [409](/filings/0002071778-26-000051.md) | [466](/filings/0001213900-25-109371.md) | [630](/filings/0002071778-26-000032.md) | [637](/filings/0002071778-26-000051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 640,467,348 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0002071778-26-000051.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.